UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.

At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims process, found overpayments humans missed, and built a credible business case.

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

UiPath Inc PATH reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. The company reported revenue of $481.11 million versus ...

UiPath (PATH) stock is selling off despite strong earnings as the market has not yet priced in whether agentic AI automation will accelerate enterprise adoption the way it did for Palantir ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

UiPath stock has tumbled as optimism around its automation software has been overtaken by concern about artificial intelligence.